Clearside takes haircut in follow-on

Clearside Biomedical Inc. (NASDAQ:CLSD), which had hoped to raise $75 million, settled for $36 million through the sale of 4 million shares at $9 in a follow-on underwritten by JPMorgan, Cowen, Stifel and Wedbush. The price is a 38% discount to Clearside’s close of $14.43 on Wednesday, before the offering was announced after market.

Clearside lost 20% on Thursday, and slipped another $2.48 (22%) to $9.05 at 3:10p on Friday...